Cargando…

Is Laser Therapy an Adjuvant in the Treatment of Peri-Implant Mucositis? A Randomized Clinical Trial

(1) Background: Early diagnosis and treatment of peri-implant mucositis may reduce inflammatory markers and halt the progression of the condition to peri-implantitis. Adjunctive laser treatment may have therapeutic benefits that are not yet well known. The aim of this study was to determine the adva...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazăr, Luminița, Dakó, Timea, Mureșan, Izabella-Éva, Suciu, Mircea, Maftei, George-Alexandru, Tatarciuc, Monica, Lazăr, Ana-Petra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047770/
https://www.ncbi.nlm.nih.gov/pubmed/36980500
http://dx.doi.org/10.3390/diagnostics13061192
_version_ 1785014010005946368
author Lazăr, Luminița
Dakó, Timea
Mureșan, Izabella-Éva
Suciu, Mircea
Maftei, George-Alexandru
Tatarciuc, Monica
Lazăr, Ana-Petra
author_facet Lazăr, Luminița
Dakó, Timea
Mureșan, Izabella-Éva
Suciu, Mircea
Maftei, George-Alexandru
Tatarciuc, Monica
Lazăr, Ana-Petra
author_sort Lazăr, Luminița
collection PubMed
description (1) Background: Early diagnosis and treatment of peri-implant mucositis may reduce inflammatory markers and halt the progression of the condition to peri-implantitis. Adjunctive laser treatment may have therapeutic benefits that are not yet well known. The aim of this study was to determine the advantages and limitations of laser therapy as an adjuvant in the treatment of peri-implant mucositis. (2) Methods: A total of 42 patients with at least 2 implants situated in different hemiarches were included in this study and divided into two groups: G1 (received laser therapy) and G2 (no laser therapy). Periodontal health status indices were recorded at the initial moment (T0), and all patients underwent non-surgical debridement therapy accompanied by oral hygiene training. In patients from group G1, one implant site received adjuvant laser therapy (subgroup IL), and the other one did not receive active laser light (IC). The plaque index (PI), probing pocket depth (PPD), and bleeding on probing (BOP) values recorded after 3 months (T1) and 6 months (T2) were analyzed and compared with those at T0. (3) Results: PI values considerably reduced at moment T1 and T2 for both G1 and G2 (p = 0.0031). PPD was also reduced, but the difference between the groups and the three recording moments was not statistically significant. Statistically significant differences were found when comparing the BOP values between G1 IL and G1 IC for T0/T1 (p = 0.0182) and T1/T2 (p < 0.0001), but there was no significant difference between G2 and G1 IL or G1 IC. (4) Conclusions: Laser therapy as an adjunct to conventional treatment of peri-implant mucositis leads to a statistically significant reduction in bleeding on probing at 3-month and 6-month re-evaluations. Moreover, it leads to an evident reduction in probing depth but with no statistical significance. These results should be interpreted with caution, and more in-depth research should be performed to create a complete laser therapy protocol for peri-implant mucositis.
format Online
Article
Text
id pubmed-10047770
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100477702023-03-29 Is Laser Therapy an Adjuvant in the Treatment of Peri-Implant Mucositis? A Randomized Clinical Trial Lazăr, Luminița Dakó, Timea Mureșan, Izabella-Éva Suciu, Mircea Maftei, George-Alexandru Tatarciuc, Monica Lazăr, Ana-Petra Diagnostics (Basel) Article (1) Background: Early diagnosis and treatment of peri-implant mucositis may reduce inflammatory markers and halt the progression of the condition to peri-implantitis. Adjunctive laser treatment may have therapeutic benefits that are not yet well known. The aim of this study was to determine the advantages and limitations of laser therapy as an adjuvant in the treatment of peri-implant mucositis. (2) Methods: A total of 42 patients with at least 2 implants situated in different hemiarches were included in this study and divided into two groups: G1 (received laser therapy) and G2 (no laser therapy). Periodontal health status indices were recorded at the initial moment (T0), and all patients underwent non-surgical debridement therapy accompanied by oral hygiene training. In patients from group G1, one implant site received adjuvant laser therapy (subgroup IL), and the other one did not receive active laser light (IC). The plaque index (PI), probing pocket depth (PPD), and bleeding on probing (BOP) values recorded after 3 months (T1) and 6 months (T2) were analyzed and compared with those at T0. (3) Results: PI values considerably reduced at moment T1 and T2 for both G1 and G2 (p = 0.0031). PPD was also reduced, but the difference between the groups and the three recording moments was not statistically significant. Statistically significant differences were found when comparing the BOP values between G1 IL and G1 IC for T0/T1 (p = 0.0182) and T1/T2 (p < 0.0001), but there was no significant difference between G2 and G1 IL or G1 IC. (4) Conclusions: Laser therapy as an adjunct to conventional treatment of peri-implant mucositis leads to a statistically significant reduction in bleeding on probing at 3-month and 6-month re-evaluations. Moreover, it leads to an evident reduction in probing depth but with no statistical significance. These results should be interpreted with caution, and more in-depth research should be performed to create a complete laser therapy protocol for peri-implant mucositis. MDPI 2023-03-21 /pmc/articles/PMC10047770/ /pubmed/36980500 http://dx.doi.org/10.3390/diagnostics13061192 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lazăr, Luminița
Dakó, Timea
Mureșan, Izabella-Éva
Suciu, Mircea
Maftei, George-Alexandru
Tatarciuc, Monica
Lazăr, Ana-Petra
Is Laser Therapy an Adjuvant in the Treatment of Peri-Implant Mucositis? A Randomized Clinical Trial
title Is Laser Therapy an Adjuvant in the Treatment of Peri-Implant Mucositis? A Randomized Clinical Trial
title_full Is Laser Therapy an Adjuvant in the Treatment of Peri-Implant Mucositis? A Randomized Clinical Trial
title_fullStr Is Laser Therapy an Adjuvant in the Treatment of Peri-Implant Mucositis? A Randomized Clinical Trial
title_full_unstemmed Is Laser Therapy an Adjuvant in the Treatment of Peri-Implant Mucositis? A Randomized Clinical Trial
title_short Is Laser Therapy an Adjuvant in the Treatment of Peri-Implant Mucositis? A Randomized Clinical Trial
title_sort is laser therapy an adjuvant in the treatment of peri-implant mucositis? a randomized clinical trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047770/
https://www.ncbi.nlm.nih.gov/pubmed/36980500
http://dx.doi.org/10.3390/diagnostics13061192
work_keys_str_mv AT lazarluminita islasertherapyanadjuvantinthetreatmentofperiimplantmucositisarandomizedclinicaltrial
AT dakotimea islasertherapyanadjuvantinthetreatmentofperiimplantmucositisarandomizedclinicaltrial
AT muresanizabellaeva islasertherapyanadjuvantinthetreatmentofperiimplantmucositisarandomizedclinicaltrial
AT suciumircea islasertherapyanadjuvantinthetreatmentofperiimplantmucositisarandomizedclinicaltrial
AT mafteigeorgealexandru islasertherapyanadjuvantinthetreatmentofperiimplantmucositisarandomizedclinicaltrial
AT tatarciucmonica islasertherapyanadjuvantinthetreatmentofperiimplantmucositisarandomizedclinicaltrial
AT lazaranapetra islasertherapyanadjuvantinthetreatmentofperiimplantmucositisarandomizedclinicaltrial